Next Phase of Nightingale

During the last year, we linked with over 150 companies from 20 countries that registered interest in developing the Nightingale ‘ultimate patient monitor’, and more than 60 then submitted either stand-alone or combined tenders.
We are delighted to say that we have now selected nine high quality proposals to go through to the next phase of the project. These nine are:

o Checkpoint Cardio (consortium)
o Cronos (consortium)
o Emfit
o HealthCareCoCreation (consortium)
o Pulso (consortium)
o SUI Generis Solutions
o Tech4Care (consortium)
o TRUST Medical Systems
o Welch Allyn

Find out more about these companies here: List of companies